期刊文献+

利奈唑胺对分枝杆菌体外抑菌作用的初步研究 被引量:28

Evaluation of the mycobactericidal efficacy of linezolid in vitro
原文传递
导出
摘要 目的评价利奈唑胺对MTB和5种非结核分枝杆菌(NTM)的体外抑菌作用,探讨利奈唑胺与其他抗结核药物联合使用时的体外相互作用。方法采用微孔板AlamarBlue法测定利奈唑胺对MTB临床株121株、NTM临床菌株30株及相应标准菌株的MIC,观察利奈唑胺与7种常用抗结核药物联合使用时,对H,,Rv和8株MTB临床分离株的MIC值的影响,通过计算分级抑菌浓度指数,观察利奈唑胺与其他抗结核药物联合使用时是否存在协同作用。结果94.2%(114/121)的MTB临床分离株可被≤1mg/L的利奈唑胺抑制生长,利奈唑胺对敏感和MDR菌株及其他形式的耐药菌株的MIC差异无统计学意义(x。=0.481,P〉0.05)。若以〉1mg/L作为耐药标准,则5种NTM菌株中仅堪萨斯分枝杆菌对利奈唑胺敏感,脓肿分枝杆菌和偶然分枝杆菌均对利奈唑胺全耐药,鸟分枝杆菌和胞内分枝杆菌对利奈唑胺部分敏感。利奈唑胺与7种抗结核药物在体外联合使用时未表现出相关性。结论利奈唑胺有很好的抗MTB活性,且与细菌对其他药物是否耐药无关。利奈唑胺对堪萨斯分枝杆菌有很好的抗菌活性,与其他常用抗结核药物联合使用时未表现出相关性。 Objective To evaluate the mycobactericidal efficacy of linezolid to Mycobacterium tuberculosis bacilli and Non-tuberculous myeobacteria (NTM) in vitro, and to analyze the interaction between linezolid and other anti-TB drugs in vitro. Methods The minimum inhibition concentrations (MICs) of 121 Mycobacterium tuberculosis clinical isolates and 30 non tuberculousis Mycobacteria isolates and the corresponding standard strains to linezolid were tested by Microplate Alamar Blue assay (MABA). The interactions between linezolid and rifampicin, isoniazid, streptomycin, ethambutol, kanamyein, ofloxacin, and rifabutin were also tested in vitro by fractional inhibitory concentration index (FICI) method. Results 94. 2% ( 114/121 ) of the Mycobacterium tuberculosis isolates were inhibited by linezolid at concentrations ~〈 1 mg/L. There was no statistical difference in the MIC values of sensitive strains, MDR strains, and drug resistant strains other than MDR (X2 = 0. 481, P 〉 0. 05 ). Only Mycobacterium kansasii was totally sensitive to linezolid among the 5 tested NTM strains. In vitro drug combination testing displayed overall non- association between linezolid and 7 other anti-TB drugs among 8 clinical isolates and H37 Rv. Conclusions Linezolid showed great mycobactericidal efficacy to Mycobacterium tuberculosis clinical isolates in vitro, regardless of the strains' drug resistant parameters. This study also showed non-association of the interactions between linezolid and 7 other anti-TB drugs in vitro.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2011年第8期575-578,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 北京市科技新星计划(20078039)
关键词 分枝杆菌 结核 利奈唑胺 微生物敏感性试验 Mycobacterium tuberculosis linezolid Microbial sensitivity tests
  • 相关文献

参考文献15

  • 1Young LS. Reconsidering some approved antimicrobial agents for tuberculosis. Antimicrob Agents Chemother, 2009. 53: 4577- 4579. 被引量:1
  • 2Nannini EC, Keating M, Binstock P, et al. Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezotid and mefloquine. J Infect, 2002, 44 : 201-203. 被引量:1
  • 3Fortun J, Martin-Davila P, Navas E, et al. Linezolid for the treatment of muhidrug-resistant tubereulosis. J Antimierob Chemother, 2005, 56: 180-185. 被引量:1
  • 4Schecter GF, Scott C, True L, et al. Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis, 2010, 50: 49- 55. 被引量:1
  • 5Anger HA, Dworkin F, Sharma S, et al. Linezolid use for treatment of muhidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06. J Antimicrob Chemother, 2010, 65: 775-783. 被引量:1
  • 6Koh WJ, Kwon O J, Gwak H, et al. Daily 300 mg dose of linezolid for the treatment of intractable muhidrug-resistant and extensively drug-resistant tuberculosis. J Antimierob Chemother, 2009, 64: 388-391. 被引量:1
  • 7Franzblau SG, Witzig RS, McLaughlin JC, et al. Rapid, low- technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol, 1998, 36: 362-366. 被引量:1
  • 8Lewis RE, Diekema DJ, Messer SA, et al. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother, 2002, 49: 345-351. 被引量:1
  • 9Huang TS, Liu YC, Sy CL, et al. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years. Antimicrob Agents Chemother, 2008, 52: 2226-2227. 被引量:1
  • 10Rodriguez JC, Ruiz M, Lopez M, et al. In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. Int J Antimicrob Agents, 2002, 20: 464-467. 被引量:1

同被引文献272

引证文献28

二级引证文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部